Key Market Insights
- Presently, more than 35 players across the globe claim to offer cell free expression services for synthesis of a variety of biomolecules
- The current market landscape is fragmented, featuring the presence of both new entrants and established players catering to needs of various industries; majority of these players are based in the US
- In pursuit of building a competitive edge in this field, stakeholders are actively upgrading their existing capabilities and adding new competencies in order to enhance their respective service portfolios
- More than 90 cell free expression kits are currently available in the market for the synthesis of different types of biomolecules; these kits utilize different types of host organisms for cell free expression
- Cell free expression kits utilize a range of cell free expression system for the synthesis of different types of biologics; majority of these include proteins, followed by oligonucleotides and others
- Owing to the rise in demand for difficult to express biomolecules, the requirement of cell free expression is increasing, prompting the stakeholders to upgrade their product offerings
- Since 2015, more than 430 patents have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field
- The growing interest is evident from the rise in partnership activity; in fact, the maximum number of collaborations related to cell free systems were inked in 2022
- Several investors having realized the opportunity within this domain, have invested more than USD 8 billion across various funding rounds in the past six years
- The cell free expression market is likely to grow at a CAGR of 7.1%, till 2035; this opportunity is expected to be well distributed across different types of cell free systems, host organisms and expression methods
- Growth in this domain is anticipated to be primarily driven by the rising demand for biologics; North America is expected to capture larger share (over 50%) of the market by 2035
Table of Contents
- PREFACE
1.1. Cell Free System Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
- EXECUTIVE SUMMARY
- INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Cell Free Systems
3.3. Overview of Cell Free Biomanufacturing
3.4. Applications of Cell Free Biomanufacturing
3.5. Future Perspectives
- MARKET LANDSCAPE: CELL FREE EXPRESSION SERVICE PROVIDERS
4.1. Chapter Overview
4.2. Cell Free Expression Service Providers: Overall Market Landscape
- MARKET LANDSCAPE: CELL FREE EXPRESSION KITS
5.1. Chapter Overview
5.2. Cell Free Expression Kits: Overall Market Landscape
5.3. Cell Free Expression Kit Providers Landscape
- CELL FREE EXPRESSION SERVICE PROVIDERS: COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Company Competitiveness Analysis: Cell Free Expression Service Providers
- CELL FREE EXPRESSION KITS: PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Cell Free Expression Kits
- COMPANY PROFILES: CELL FREE EXPRESSION SERVICE PROVIDERS
8.1. Chapter Overview
8.2. BioLinker
8.2.1. Company Overview
8.2.2. Cell Free Expression Service Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. CUSABIO
8.4. LenioBio
8.5. Touchlight
- COMPANY PROFILES: CELL FREE EXPRESSION KIT PROVIDERS
9.1. Chapter Overview
9.2. biotechrabbit
9.3. CellFree Sciences
9.4. Creative Biolabs
9.5. Diacel Arbor Biosciences
9.6. Promega
9.7. Thermo Fisher Scientific
- PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Cell free System: Partnerships and Collaborations
- FUNDING AND INVESTMENT ANALYSIS
11.1. Chapter Overview
11.2. Types of Funding
11.3. Cell free System: Funding and Investment Analysis
- PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Cell free System: Patent Analysis
12.4. Cell free System: Patent Benchmarking Analysis
12.5. Cell free System: Patent Valuation
12.6. Leading Patents: Analysis by Number of Citations
- MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Global Cell Free Market, 2023-2035
- EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Gene Frontier
14.3. LenioBio
14.4. Synthelis
15.CONCLUDING REMARKS
- APPENDIX 1: TABULATED DATA
- APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html
Learn from experts: do you know about these emerging industry trends?
Modular Construction – Retrofitting Conventional Buildings
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
